Knowledge, attitudes, and communication around human papillomavirus (HPV) vaccination amongst urban Asian mothers and physicians

被引：58

作者：

Chow, Song-Nan ^{[1
,2
]}

Soon, Ruey ^{[3
]}

Park, Jong Sup ^{[4
]}

Pancharoen, Chitsanu ^{[5
]}

Qiao, You Lin ^{[6
]}

Basu, Partha ^{[7
]}

Ngan, Hextan Yuen Sheung ^{[8
]}

机构：

[1] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei 100, Taiwan

[2] Min Sheng Gen Hosp, Gynecol Oncol Res Ctr, Taoyoun, Taiwan

[3] Sabah Womens & Childrens Hosp, Dept Obstet & Gynecol, Likas Hosp, Kota Kinabalu 88996, Sabah, Malaysia

[4] Catholic Univ Korea, Coll Med, Dept Obstet & Gynecol, Seoul St Marys Hosp, Seoul 137701, South Korea

[5] Chulalongkorn Hosp, Dept Pediat, Bangkok 10330, Thailand

[6] Chinese Acad Med Sci, Canc Inst & Hosp, Beijing 10021, Peoples R China

[7] Chittaranjan Natl Canc Inst, Dept Gynecol Oncol, Kolkata 700026, India

[8] Univ Hong Kong, Queen Mary Hosp, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China

来源：

VACCINE | 2010年 / 28卷 / 22期

关键词：

HPV; vaccination; Survey; Barriers to uptake; CERVICAL-CANCER; HONG-KONG; MULTIETHNIC POPULATIONS; DEVELOPING-COUNTRY; PARTICLE VACCINE; WOMEN; EPIDEMIOLOGY; ACCEPTABILITY; INFECTIONS; EFFICACY;

D O I：

10.1016/j.vaccine.2010.03.027

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

To determine why HPV vaccination uptake is low in Asia, we surveyed attitudes, knowledge and communication about cervical cancer and HPV vaccination amongst 480 physicians and 1617 randomly selected urban mothers who could afford HPV vaccines in Korea, Malaysia, Taiwan and Thailand. HPV vaccine rejection by mothers was linked with poor knowledge and low perceptions of self-relevance. Physicians' likelihood of raising the subject and/or recommending vaccination was linked to how proactively they advocate preventive health, their attitude to the subject's sensitivity and their knowledge levels. Because most Asian mothers seek doctors' advice and prefer them to take the initiative, physicians should be more proactive in discussing and recommending HPV vaccination. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：3809 / 3817

页数：9

共 24 条

[1] The epidemiology of human papillomavirus infections
Baseman, JG
Koutsky, LA
[J]. JOURNAL OF CLINICAL VIROLOGY, 2005, 32 : S16 - S24
[2] Sociocultural Issues in the Introduction of Human Papillomavirus Vaccine in Low-Resource Settings
Bingham, Allison
Drake, Jennifer Kidwell
LaMontagne, D. Scott
[J]. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2009, 163 (05): : 455 - 461
[3] Literature review of human papillomavirus vaccine acceptability among women over 26 years
Black, Lora L.
Zimet, Gregory D.
Short, Mary B.
Sturm, Lynne
Rosenthal, Susan L.
[J]. VACCINE, 2009, 27 (11) : 1668 - 1673
[4] The causal relation between human papillomavirus and cervical cancer
Bosch, FX
Lorincz, A
Muñoz, N
Meijer, CJLM
Shah, KV
[J]. JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (04) : 244 - 265
[5] A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women
Brown, DR
Shew, ML
Qadadri, B
Neptune, N
Vargas, M
Tu, WZ
Juliar, BE
Breen, TE
Fortenberry, JD
[J]. JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (02) : 182 - 192
[6] HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives
Castellsague, Xavier
Schneider, Achim
Kaufmann, Andreas M.
Xavier Bosch, F.
[J]. GYNECOLOGIC ONCOLOGY, 2009, 115 (03) : S15 - S23
[7] Ferlay J., 2002, Cancer Incidence, Mortality and Prevalence Worldwide, GLOBOCAN 2002, IARC Cancer Base N˚5
[8] The need for public education on HPV and cervical cancer prevention in Asia Opinions of experts at the AOGIN Conference
Garland, S.
Park, S. N.
Ngan, H. Y. S.
Frazer, I.
Tay, E. H.
Chen, C. J.
Bhatla, N.
Pitts, M.
Shin, H. R.
Konno, R.
Smith, J.
Pagliusi, S.
Park, J. S.
[J]. VACCINE, 2008, 26 (43) : 5435 - 5440
[9] *GLAXOSMITHKLINE, 2008, BIOL DAT FIL
[10] Sustained efficacy up to 4-5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
Harper, DM
Franco, EL
Wheeler, CM
Moscicki, AB
Romonowski, B
Roteli-Martins, CM
Jenkins, D
Schuind, A
Clemens, SAC
Dubin, G
[J]. LANCET, 2006, 367 (9518) : 1247 - 1255

← 1 2 3 →